aurobindo pharma under pressure after us fda issues warning letter for eugia unit iii | cnbc tv18
Published 4 weeks ago • 441 plays • Length 2:35Download video MP4
Download video MP3
Similar videos
-
3:24
aurobindo pharma under pressure after us fda issues 9 observations for eugia pharma's unit iii
-
3:02
aurobindo pharma under pressure after us fda warning letter, divi's lab rises on positive news
-
1:37
aurobindo pharma surges as eugia steriles' andhra facility gets first us fda approval for injectable
-
1:43
usfda inspection of eugia-iii unit of aurobindo pharma underway, stock under pressure | cnbc tv18
-
0:50
#shorts | usfda inspects pharma space
-
5:01
these sectors could benefit most from a fed rate cut
-
4:23
ace investor rakesh jhunjhunwala quizzes n govindarajan of aurobindo pharma
-
1:43
usfda issues 9 observations to aurobindo pharma's injectable arm which could dent us sales | et now
-
0:57
why aurobindo pharma stock is under pressure? n18s | cnbctv18
-
2:31
u.s. fda issues 10 observations to aurobindo pharma under form 483 | halftime report | cnbc-tv18
-
1:16
aurobindo pharma temporarily halts production at eugia’s unit-iii after 9 us fda observations
-
17:15
aurobindo pharma: unit 4 | us fda blow; issues 9 observations to unit 4 | cnbc tv18
-
1:43
will submit response on us fda observations on eugia 3 unit by feb 26, confirms aurobindo pharma
-
1:54
aurobindo pharma's arm apl healthcare units get vai status from u.s. fda | halftime report
-
1:32
aurobindo pharma's key unit inspected by us fda with zero observations
-
2:02
zydus life's jarod facility receives fda warning; granules's gagillapur receives 6 observations
-
1:15
aurobindo pharma gets 3 us fda approvals overnight
-
8:09
aurobindo pharma's unit-iv plant gets clearance from us fda | midcap radar
-
0:56
aurobindo pharma’s unit 7 cleared with zero observations
-
0:37
d-street chatter: what's buzzing at the dealers' desk? | aurobindo pharma | vedanta | n18s
-
12:21
aurobindo pharma stock closes 3% lower after firm recalls blood pressure drug from us market
-
2:46
global pharma recalls eye drops from us market after usfda, us cdc issue warning | cnbc-tv18